The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Earnings playbook: Tech giants Apple and Meta Platforms lead a busy week of reports
The busiest week of the earnings season is here, with some of the world’s largest tech companies slated to report.
Barclays prefers Germany over France as it sends ‘bond vigilante’ warning
French borrowing costs drew level with Greece’s for the first time on record this week, showing the extent of market concerns.
Ken Griffin says Trump’s ‘bombastic’ trade rhetoric is a mistake that’s eroding trust in the U.S.
The billionaire hedge fund founder’s comments came after Trump on Monday evening signed an order that would impose 25% tariffs on steel and aluminum imports.